DermTech, Inc.
DMTKQ · OTC
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $3,845 | $3,924 | $3,915 | $3,980 |
| % Growth | -2% | 0.2% | -1.6% | – |
| Cost of Goods Sold | $3,132 | $3,484 | $3,743 | $3,972 |
| Gross Profit | $713 | $440 | $172 | $8 |
| % Margin | 18.5% | 11.2% | 4.4% | 0.2% |
| R&D Expenses | $3,266 | $3,348 | $3,595 | $3,887 |
| G&A Expenses | $10,138 | $8,422 | $8,264 | $15,220 |
| SG&A Expenses | $17,955 | $16,844 | $16,387 | $28,253 |
| Sales & Mktg Exp. | $7,817 | $8,422 | $8,123 | $13,033 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21,221 | $20,192 | $19,982 | $32,140 |
| Operating Income | -$20,508 | -$19,752 | -$19,810 | -$32,132 |
| % Margin | -533.4% | -503.4% | -506% | -807.3% |
| Other Income/Exp. Net | $498 | $661 | $646 | $769 |
| Pre-Tax Income | -$20,010 | -$19,091 | -$19,164 | -$31,363 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$20,010 | -$19,091 | -$19,164 | -$31,363 |
| % Margin | -520.4% | -486.5% | -489.5% | -788% |
| EPS | -0.58 | -0.56 | -0.57 | -0.99 |
| % Growth | -3.6% | 1.8% | 42.4% | – |
| EPS Diluted | -0.58 | -0.56 | -0.57 | -0.99 |
| Weighted Avg Shares Out | 34,706 | 34,327 | 33,835 | 31,792 |
| Weighted Avg Shares Out Dil | 34,706 | 34,327 | 33,835 | 31,792 |
| Supplemental Information | – | – | – | – |
| Interest Income | $498 | $660 | $641 | $763 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,406 | $1,346 | $1,348 | $1,479 |
| EBITDA | -$19,102 | -$18,406 | -$18,462 | -$30,653 |
| % Margin | -496.8% | -469.1% | -471.6% | -770.2% |